Multiple Myeloma News and Research

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.

Interim data from Geron's ongoing imetelstat trial presented at the AACR-NCI-EORTC conference

19. November 2009 08:11

Geron Corporation today announced the presentation of interim data from its ongoing trial of imetelstat (GRN163L), a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. [More]

e6bee6e2-9009-4237-81ca-1e4e9a4d346e|1|5.0

Posted in: Drug Trial News | Medical Condition News

Tags: Cancer, Cell, Diabetes, Heart Failure, Multiple Myeloma, Oncology, Thrombocytopenia, Vaccine, Xenograft

Winship-led team identifies a way to exploit cancer cells' taste for glucose

19. November 2009 05:07

The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered. [More]

ac27c2f4-05c7-436e-a5b6-4a6387e288fc|0|.0

Posted in: Medical Science News | Medical Condition News

Tags: Biotechnology, Cancer, Cell, Hematology, Hospital, Metabolism, Multiple Myeloma, Nursing, Oncology, Spine

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

18. November 2009 10:31

Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company’s second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March. [More]

a61a65ac-e150-48dc-bb4d-d91e79fc3c1c|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abdominal Pain, Anemia, Anorexia, Anxiety, Arthralgia, Blindness, Bone, Cancer, Cell, Constipation, Cough, Dehydration, Diarrhea, Doxorubicin, Dyspnea, Edema, Headache, Heart Failure, Herpes, Herpes Zoster, Hypersensitivity, Insomnia, Liposome, Lymphoma, Multiple Myeloma, Nausea, Neuropathy, Neutropenia, Nursing, Oncology, Peripheral Neuropathy, Pneumonia, Thrombocytopenia, Ubiquitin, Vomiting

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

18. November 2009 08:40

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models. [More]

7105e9d6-13ab-4fd4-afa9-3e55eccba03a|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Acute Lymphoblastic Leukemia, Apoptosis, Breast Cancer, Cancer, Cell, Chronic Myeloid Leukemia, Colon Cancer, Erlotinib, Gleevec, Hospital, Leukemia, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Myeloid Leukemia, Non-Small Cell Lung Cancer, Oncology, Paclitaxel, Pancreatic Cancer, Prostate Cancer, Small Cell Lung Cancer, Sunitinib, Tarceva, Xenograft

First-quarter fiscal 2010 results announced by Senesco Technologies

17. November 2009 09:04

Senesco Technologies, Inc. today reported financial results for the three months ended September 30, 2009. [More]

55e71b96-6bc1-4607-a5ce-493ade991843|0|.0

Posted in: Business / Finance

Tags: Apoptosis, Biotechnology, Cancer, Cell, Multiple Myeloma, Oncology, Stress

Scientists solve 50-year-old thalidomide puzzle

17. November 2009 06:13

Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments for Leprosy, Crohn's Disease, AIDS and some forms of cancer.. [More]

b7508db8-60cd-417a-9798-04d1c4018d4b|0|.0

Posted in: Pharmaceutical News

Tags: Angiogenesis, Cancer, Crohn's Disease, Leprosy, Multiple Myeloma, Thalidomide

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

16. November 2009 10:40

Seattle Genetics, Inc. today announced that it has initiated a phase I clinical trial of SGN-75 for metastatic renal cell carcinoma and relapsed and refractory non-Hodgkin lymphoma. SGN-75 is an antibody-drug conjugate (ADC) targeting CD70 that utilizes the company’s proprietary technology. [More]

c39fca64-5a76-4779-9918-3fae4e22b2af|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Antibody, Autoimmune Disease, Biotechnology, Brentuximab Vedotin, Cancer, Cell, Genetics, Glioblastoma, Kidney Cancer, Lymphoma, Monoclonal Antibody, Multiple Myeloma, Oncology, Renal Cell Carcinoma

Onyx Pharmaceuticals acquires Proteolix

16. November 2009 10:13

Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors. [More]

0fbc4325-e7b3-48da-b125-a399eb516f59|0|.0

Posted in: Business / Finance | Pharmaceutical News

Tags: Bone, Bone Marrow, Cancer, Evolution, Kidney Cancer, Liver Cancer, Multiple Myeloma, Nexavar, Sorafenib

Myeloma UK launches innovative clinical trial network

16. November 2009 08:29

Yorkshire myeloma patients are set to be among the first to benefit from an innovative Myeloma Clinical Trial Network launched by Myeloma UK. [More]

d79196c0-69a0-4cd3-a17d-377e554c5d49|1|5.0

Posted in: Device / Technology News | Medical Condition News

Tags: Bone, Bone Marrow, Cancer, Hospital, Investment, Multiple Myeloma, Oncology, Rare Disease

EntreMed announces financial results for the third quarter of 2009

16. November 2009 07:37

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for the three- and nine-month periods ending September 30, 2009. [More]

14ca50e1-e12c-4049-95c4-2e93a400190e|0|.0

Posted in: Business / Finance

Tags: Arthritis, Cancer, Cell, Kinase Inhibitor, Leukemia, Multiple Myeloma, Rheumatoid Arthritis

PAF receives additional funding support for serving patients with multiple myeloma

13. November 2009 05:50

Patient Advocate Foundation (PAF) -- a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases -- is pleased to announce that it has received additional funding support for serving patients with multiple myeloma through its Co-Pay Relief Program (CPR). [More]

d4fa4f2b-a570-4e1b-b0fe-55874212d304|0|.0

Posted in: Medical Condition News | Healthcare News

Tags: Cancer, Cell, CPR, Medicare, Multiple Myeloma

Senesco Technologies to present data on its multiple myeloma drug candidate at the AACR-NCI-EORTC conference

12. November 2009 11:00

Senesco Technologies, Inc. announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference. [More]

fed0db4a-35ab-4f99-b105-245df7e8e54e|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Apoptosis, Biotechnology, Cancer, Cell, Multiple Myeloma, Stress

Keryx Biopharmaceuticals to present KRX-0401 Phase 1/2 clinical trial data at the ASH meeting

12. November 2009 04:36

Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009. [More]

5f43057f-4604-4f13-818b-813998399100|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Cancer, Cell, Hematology, Multiple Myeloma, Perifosine

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

11. November 2009 07:39

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results as at and for the three-month and nine-month periods ended September 30, 2009. [More]

93a76b2d-c90e-47a0-9040-328ab97e6a50|0|.0

Posted in: Business / Finance

Tags: Alcohol Dependence, Benign Prostatic Hyperplasia, Cancer, Cetrorelix, Endocrinology, Ghrelin, Growth Hormone, Investment, Lymphoma, Multiple Myeloma, Oncology, Ovarian Cancer, Perifosine

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

11. November 2009 03:16

Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma. [More]

1ee7146d-466b-4804-913b-c5dff8790c44|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Cancer, Hematology, Hospital, Kidney Cancer, Liver Cancer, Lymphoma, Multiple Myeloma, Nexavar, Oncology, Sorafenib

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Multiple Myeloma News and Research

Interim data from Geron's ongoing imetelstat trial presented at the AACR-NCI-EORTC conference

Winship-led team identifies a way to exploit cancer cells' taste for glucose

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

First-quarter fiscal 2010 results announced by Senesco Technologies

Scientists solve 50-year-old thalidomide puzzle

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Onyx Pharmaceuticals acquires Proteolix

Myeloma UK launches innovative clinical trial network

EntreMed announces financial results for the third quarter of 2009

PAF receives additional funding support for serving patients with multiple myeloma

Senesco Technologies to present data on its multiple myeloma drug candidate at the AACR-NCI-EORTC conference

Keryx Biopharmaceuticals to present KRX-0401 Phase 1/2 clinical trial data at the ASH meeting

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

Recent Articles

Free!

Recent Comments

Twitter

Information

Multiple Myeloma News and Research

Medical News Cloud

Recent Articles